뇌정위적 방사선수술 시 콜리메이터 크기 변화에 따른 검출기 의존성 평가

배용기,방동완,박병문,강민영,김연래,Bae, Yong-Ki,Bang, Dong-Wan,Park, Byung-Moon,Kang, Min-Yeong,Kim, Yeon-Rye 대한방사선치료학회 2008 대한방사선치료학회지 Vol.20 No.2

Purpose: To evaluate the detector dependency in the various collimator size for Stereotactic Radiosugery (SRS). Materials and Methods: This study was performed with 6 MV photon beam (Varian 21EX, Varian, US) and the measurement detectors are used by ion chamber CC01, CC13 (Wellhofer, Germany) and stereotactic diode detector (SFD, Wellhofer, Germany). SRS collimator size was used by ${\varphi}$5, 10, 20, 30 mm (Brain Lab, Germany). Percentage depth dose (PDD) was measured at SSD 100 cm and field size 10×10 cm from individual detectors. Ouput factor was measured by using same setup of PDD and with maximum dose depth. Data was normalized at field size $10{\times}10\;cm$. Beam profile was measured at SSD 100 cm in SRS collimator ${\varphi}$10, 30 mm and field $10{\times}10\;cm$ and a comparison of FWHM (full width half maximum), penumbra width (20~80%). Results: The CC13 detector was overestimated 16% than other detectors from the PDD in the 5 mm collimator. Output factors were underestimated CC01 28%, CC13 72% in the 5 mm collimator and CC01 9.6%, CC13 25% in the 10 mm collimator than the SFD. Maximum difference was 3% at the FWHM of the dose profile in the 10 mm collimator and difference of the 30 mm collimator was 0% at the FWHM. Penumbra width was increased CC01 122%, CC13 194% in the 10 mm collimator and CC01 68%, CC13 185% in the 30 mm collimator than the SFD. Conclusion: It is very important for accurate dosimetry to select a detector in small field. The SFD was considered with the most accurate dosimeter for small collimator dosimetry in this study.

Analysis of the Dose Distribution of Moving Organ using a Moving Phantom System

김연래,박병문,배용기,강민영,이귀원,방동완,Kim, Yon-Lae,Park, Byung-Moon,Bae, Yong-Ki,Kang, Min-Young,Lee, Gui-Won,Bang, Dong-Wan Korean Society for Radiation Therapy 2006 대한방사선치료학회지 Vol.18 No.2

Purpose: Few researches have been peformed on the dose distribution of the moving organ for radiotherapy so far. In order to simulate the organ motion caused by respiratory function, multipurpose phantom and moving device was used and dosimetric measurements for dose distribution of the moving organs were conducted in this study. The purpose of our study was to evaluate how dose distributions are changed due to respiratory motion. Materials and Methods: A multipurpose phantom and a moving device were developed for the measurement of the dose distribution of the moving organ due to respiratory function. Acryl chosen design of the phantom was considered the most obvious choice for phantom material. For construction of the phantom, we used acryl and cork with density of $1.14g/cm^3,\;0.32g/cm^3$ respectively. Acryl and cork slab in the phantom were used to simulate the normal organ and lung respectively. The moving phantom system was composed of moving device, moving control system, and acryl and cork phantom. Gafchromic film and EDR2 film were used to measure dose ditrbutions. The moving device system may be driven by two directional step motors and able to perform 2 dimensional movements (x, z axis), but only 1 dimensional movement(z axis) was used for this study. Results: Larger penumbra was shown in the cork phantom than in the acryl phantom. The dose profile and isodose curve of Gafchromic EBT film were not uniform since the film has small optical density responding to the dose. As the organ motion was increased, the blurrings in penumbra, flatness, and symmetry were increased. Most of measurements of dose distrbutions, Gafchromic EBT film has poor flatness and symmetry than EDR2 film, but both penumbra distributions were more or less comparable. Conclusion: The Gafchromic EBT film is more useful as it does not need development and more radiation dose could be exposed than EDR2 film without losing film characteristics. But as response of the optical density of Gafchromic EBT film to dose is low, beam profiles have more fluctuation at Gafchromic EBT. If the multipurpose phantom and moving device are used for treatment Q.A, and its corrections are made, treatment quality should be improved for the moving organs.

세기변조방사선치료의 품질관리를 위한 이온전리함 매트릭스의 유용성 고찰

강민영,김연래,박병문,배용기,방동완,Kang, Min-Young,Kim, Yoen-Lae,Park, Byung-Moon,Bae, Yong-Ki,Bang, Dong-Wan 대한방사선치료학회 2007 대한방사선치료학회지 Vol.19 No.2

Purpose: To evaluate the feasibility of a commercial ion chamber array for intensity modulated radiation therapy (IMRT) quality assurance (QA) was performed IMRT patient-specific QA Materials and Methods: A use of IMRT patient-specific QA was examined for nasopharyngeal patient by using 6MV photon beams. The MatriXX (Wellhofer Dosimetrie, Germany) was used for IMRT QA. The case of nasopharyngeal cancer was performed inverse treatment planning. A hybrid dose distribution made on the CT data of MatriXX and solid phantom all of the same gantry angle (0$^\circ$). The measurement was acquired with geometrical condition that equal to hybrid treatment planning. The $\gamma$-index (dose difference 3%, DTA 3 mm) histogram was used for quantitative analysis of dose discrepancies. An absolute dose was compared at the high dose low gradient region. Results: The dose distribution was shown a good agreement by gamma evaluation. A proportion of acceptance criteria was 95.8%, 97.52%, 96.28%, 98.20%, 97.78%, 96.64% and 92.70% for gantry angles were 0$^\circ$, 55$^\circ$, 110$^\circ$, 140$^\circ$, 220$^\circ$, 250$^\circ$ and 305$^\circ$, respectively. The absolute dose in high dose low gradient region was shown reasonable agreement with the RTP calculation within $\pm$3%. Conclusion: The MatriXX offers the dosimetric characteristics required for performing both relative and absolute measurements. If MatriXX use in the clinic, it could be simplified and reduced the IMRT patient-specific QA workload. Therefore, the MatriXX is evaluated as a reliable and convenient dosimeter for IMRT patient-specific QA.

유방암 절선조사 시 종속조사면 병합방법의 불균등한 선량분포 확인

박병문(Byung-Moon Park),배용기(Yong-Ki Bae),강민영(Min-Young Kang),방동완(Dong-Wan Bang),김연래(Yon-Lae Kim),이정우(Jeong-Woo Lee) 대한방사선과학회(구 대한방사선기술학회) 2010 방사선기술과학 Vol.33 No.3

본 연구의 목적은 유방암 환자의 절선조사 시 종속조사면 병합(FIF) 치료방법을 2차원 이온전리함을 이용하여 불균등한 선량분포를 확인하고자하였다. 실험을 위해 2차원 이온전리함 배열(MatriXX, Wellhofer Dosimetrie, Germany)와 치료계획장치(Eclipse, ver 6.5, Varian, Palo Alto, USA)가 사용되었다. 불균등한 선량분포 확인을 위해 FIF 방법으로 치료계획 한 20명의 환자를 선택하여 각각 90 cGy를 처방하여 하이브리드 계획을 수행하였으며, 측정값과 비교를 위해 동일한 기하학적 조건에서 MatriXX를 이용해 측정하였다. 정량적인 분석을 위해 상용화된 분석 소프트웨어(OmniPro IMRT, ver, 1.4, Wellhofer, Dosimetrie, Germany)를 이용하여 분석하였다. 실험 결과로 기준점에 선량처방 시 계산값과 측정값이 평균 1.6% 차이를 보였고, 선형프로파일 (Line-Profile)을 통해 분석한 결과 종단면에서는 1.3-5.5%(평균 : 2.4%), 횡단면에서는 0.9-3.9%(평균 : 2.5%)로 변동을 보였다. 감마인덱스 히스토그람(기준 : 3 mm, 3%)로 분석한 결과 90.23-99.69%(평균 :95.11%, 표준편차 : 2.81) 범위를 나타냈다(유효범위 ; γ-index ≥ 1). 본 실험에서는 MatriXX 이용하여 측정한 결과 치료계획 선량과 측정값이 오차범위 이내로 일치하였으며, 향후 다양한 종양치료에 있어 FIF방법의 활용도를 높이는 연구가 필요하다고 생각한다. The study is to verify non-uniform dose distribution in Field-In-Field (FIF) technique using two-di-mensional ionization chamber (MatriXX, Wellhofer Dosimetrie, Germany) for breast tangential irradiation. The MatriXX and an inverse planning system (Eclipse, ver 6.5, Varian, Palo Alto, USA) were used. Hybrid plans were made from the original twenty patients plans. To verify the non-uniform dose distribution in FIF technique, each portal prescribed doses (90 cGy) was delivered to the MatriXX. The measured doses on the MatriXX were compared to the planned doses. The quantitative analyses were done with a com-mercial analyzing tool (OmniPro IMRT, ver. 1.4, Wellhofer Dosimetrie, Germany). The delivered doses at the normalization points were different to average 1.6% between the calculated and the measured. In analysis of line profiles, there were some differences of 1.3-5.5% (Avg: 2.4%), 0.9-3.9% (Avg: 2.5%) in longitudinal and transverse planes respectively. For the gamma index (criteria: 3 mm, 3%) analyses, there were shown that 90.23-99.69% (avg: 95.11%, std: 2.81) for acceptable range (γ -index ≥ 1) through the twenty patients cases. In conclusion, through our study, we have confirmed the availability of the FIF technique by comparing the calculated with the measured using MatriXX. In the future, various clinical applications of the FIF techniques would be good trials for better treatment results.

Dosimetric Characteristics of Edge $Detector^{TM}$ in Small Beam Dosimetry

장경환,이보람,김유현,최경식,이정석,박병문,배용기,홍세미,이정우,Chang, Kyung-Hwan,Lee, Bo-Ram,Kim, You-Hyun,Choi, Kyoung-Sik,Lee, Jung-Seok,Park, Byung-Moon,Bae, Yong-Ki,Hong, Se-Mie,Lee, Jeong-Woo Korean Society of Medical Physics 2009 의학물리 Vol.20 No.4

이 연구의 목적은 소조사면 선량계측을 위하여 엣지검출기의 성능을 평가하기 위함이다. 다양한 소조사면과 깊이에서 엣지검출기(Model 1118 Edge)를 이용하여 6 MV 광자선의 선량 직선성, 선량률 의존도, 출력 계수, 선량 측면도 및 심부선량 백분율을 따라 측정하였으며, 이를 표준용적의 이온전리함(CC13)과 광자선 다이오드 검출기(PFD)와 비교하였다. 선량 직선성을 일차 선형 맞춤 함수와 비교하였을 때, 세 검출기 모두 1% 미만의 차이를 나타냈으며, 엣지검출기는 -0.08~0.08%의 가장 낮은 차이를 보였다. 선량율의 변화(100~600 MU/min)에 따라 PFD와 엣지검출기의 정규화된 반응비는 1% 미만의 일정한 값을 보였으나, CC13은 100 MU/min에서 약 -5%의 변화를 나타냈다. 조사면의 크기($4{\times}4\;cm^2{\sim}10{\times}10\;cm^2$)에 따른 출력계수는 세 검출기 모두 거의 같은 값을 보였으나, $4{\times}4\;cm^2$ 이하의 소조사면에서는 엣지검출기와 PFD의 출력 계수가 CC13과 최대 21%의 차이보였다. 각 조사면에서 20~80%의 반음영 폭을 측정하였을 때, 평균적으로 CC13은 엣지검출기보다 2배, PFD는 약 30% 정도 더 넓게 나타났다. 또한 10~90%의 반음영의 경우, CC13과 PFD가 각각 55%와 19% 정도 더 넓은 폭을 나타냈다. 엣지검출기는 선량 측면도의 반치폭이 조사면의 크기와 거의 일치하였으나, 다른 두 검출기는 조사면의 크기보다 약 8~10% 더 크게 나타났으며, 심부선량백분율은 각 조사면에서 세 검출기 모두 거의 일치하였다. 엣지검출기의 성능평가를 위한 선량특성을 분석한 결과, $4{\times}4\;cm^2$ 이하의 소조사면에서 가장 적합한 특성을 나타냈으며, CC13과 PFD와 같은 검출기는 조사면이 작을수록 상당한 오차를 나타낼 수 있음을 알 수 있었다. In this study, we evaluated an edge detector for small-beam dosimetry. We measured the dose linearity, dose rate dependence, output factor, beam profiles, and percentage depth dose using an edge detector (Model 1118 Edge) for 6-MV photon beams at different field sizes and depths. The obtained values were compared with those obtained using a standard volume ionization chamber (CC13) and photon diode detector (PFD). The dose linearity results for the three detectors showed good agreement within 1%. The edge detector had the best linearity of ${\pm}0.08%$. The edge detector and PFD showed little dose rate dependency throughout the range of 100~600 MU/min, while CC13 showed a significant discrepancy of approximately -5% at 100 MU/min. The output factors of the three detectors showed good agreement within 1% for the tested field sizes. However, the output factor of CC13 compared to the other two detectors had a maximum difference of 21% for small field sizes (${\sim}4{\times}4\;cm^2$). When analyzing the 20~80% penumbra, the penumbra measured using CC13 was approximately two times wider than that using the edge detector for all field sizes. The width measured using PFD was approximately 30% wider for all field sizes. Compared to the edge detector, the 10~90% penumbras measured using the CC13 and PFD were approximately 55% and 19% wider, respectively. The full width at half maximum (FWHM) of the edge detector was close to the real field size, while the other two detectors measured values that were 8~10% greater for all field sizes. Percentage depth doses measured by the three detectors corresponded to each other for small beams. Based on the results, we consider the edge detector as an appropriate small-beam detector, while CC13 and PFD can lead to some errors when used for small beam fields under $4{\times}4\;cm^2$.

Development of Preliminary Quality Assurance Software for $GafChromic^{(R)}$ EBT2 Film Dosimetry

박지연,이정우,최경식,홍세미,박병문,배용기,정원균,서태석,Park, Ji-Yeon,Lee, Jeong-Woo,Choi, Kyoung-Sik,Hong, Semie,Park, Byung-Moon,Bae, Yong-Ki,Jung, Won-Gyun,Suh, Tae-Suk Korean Society of Medical Physics 2010 의학물리 Vol.21 No.1

GafChromic EBT2 필름 dosimetry에 필요한 품질 관리용 소프트웨어를 개발하였다. 개발한 프로그램에서는 EBT2 필름특성에 맞게 붉은색, 초록색, 파란색 및 회색 채널에 따른 필름 교정이 가능하도록 하였다. 또한 평판형 스캐너의 빛의 산란 효과나 필름 내 방사선에 반응하는 물질(active layer)의 두께 차이가 선량 검증에 미치는 영향을 평가할 수 있도록 하였다. EBT2 필름을 이용한 측정 결과는 방사선 치료계획 시스템, ECLIPSE 또는 2차원 이온 전리함 배열의 선량 값과 비교할 수 있다. 개발한 소프트웨어를 이용한 GafChromic EBT2 필름의 선량 검증은 파일 입력, 잡음 제거, 배경 보정(background) 및 반응 물질 보정(active layer correction), 선량 계산 및 평가 단계를 통해서 이루어진다. 절대적 또는 상대적 배경 보정 방법을 선택적으로 적용할 수 있으며 필름 교정 결과 및 교정 곡선에 대한 적합식(fitting equation)은 결과 파일로 출력할 수 있다. 선량 행렬의 화소 크기 조정을 위한 보간법, 대화식 영상 이동 및 회전 기능을 이용하여 선량 행렬 간 구조적 위치를 일치시킨 후, 빔 측면도(beam profile) 및 등선량곡선(isodose curve)을 비교할 수 있다. 또한 거리 및 선량 차이에 대한 허용값을 적용하여 gamma index 및 gamma histogram을 이용한 선량 분석이 가능하다. 60도 동적 쐐기 조사면과 전립선 세기조절방사선치료의 조사면을 이용하여 개발한 소프트웨어의 기초 성능 평가를 수행하였을 때, 동적 쐐기 조사면에서 ECLIPSE와 EBT2 필름 간 절대적 빔 측면도는 3% 오차 범위 내에서 일치하였다. EBT2 필름을 이용한 두 종류의 선량 검증 모두, 99% 이상의 영역이 3 mm, 3%의 gamma index의 평가 기준을 만족하였다. 개발한 선량 검증용 소프트웨어를 이용하여 주기적으로 수행되는 일반적인 품질관리뿐만 아니라 빔의 세기가 조절된 복잡한 조사면의 품질관리에도 활용할 수 있으며, Radiochromic 필름을 이용한 선량 평가에 필요한 유용한 분석 툴을 제공할 수 있다. Software for GafChromic EBT2 film dosimetry was developed in this study. The software provides film calibration functions based on color channels, which are categorized depending on the colors red, green, blue, and gray. Evaluations of the correction effects for light scattering of a flat-bed scanner and thickness differences of the active layer are available. Dosimetric results from EBT2 films can be compared with those from the treatment planning system ECLIPSE or the two-dimensional ionization chamber array MatriXX. Dose verification using EBT2 films is implemented by carrying out the following procedures: file import, noise filtering, background correction and active layer correction, dose calculation, and evaluation. The relative and absolute background corrections are selectively applied. The calibration results and fitting equation for the sensitometric curve are exported to files. After two different types of dose matrixes are aligned through the interpolation of spatial pixel spacing, interactive translation, and rotation, profiles and isodose curves are compared. In addition, the gamma index and gamma histogram are analyzed according to the determined criteria of distance-to-agreement and dose difference. The performance evaluations were achieved by dose verification in the $60^{\circ}$-enhanced dynamic wedged field and intensity-modulated (IM) beams for prostate cancer. All pass ratios for the two types of tests showed more than 99% in the evaluation, and a gamma histogram with 3 mm and 3% criteria was used. The software was developed for use in routine periodic quality assurance and complex IM beam verification. It can also be used as a dedicated radiochromic film software tool for analyzing dose distribution.

USB 등시성 전송의 병목현상 감소를 위한 스케줄링 기법

정해성(Hae-Seong Jeong),박종강(Jong-Kang Park),변용기(Yong-Ki Byun),배대진(Dae-Jin Bae),김종태(Jong-Tae Kim) 대한전자공학회 2006 대한전자공학회 학술대회 Vol.2006 No.11

보존적 유방절제 환자의 방사선치료 시 종속조사면 병합방법에 따른 반대편 유방의 표면선량평가

박병문(Byung-Moon Park),방동완(Dong-Wan Bang),배용기(Yong-Ki Bae),이정우(Jeong-Woo Lee),김유현(You-Hyun Kim) 대한방사선과학회(구 대한방사선기술학회) 2008 방사선기술과학 Vol.31 No.4

목 적 : 종속조사면 병합 치료방법(FIF : Field In Field)을 이용한 유방절선조사 시 반대편 유방의 표면선량을 평가하고자 한다. 대상 및 방법 : FIF치료방법 이용 시 반대편 유방에 흡수되는 표면선량을 평가하고자 동일한 기하학적 조건과 처방선량을 기반으로 열린조사면(Open), 금속쐐기(MW : Metal Wedge), 동적쐐기(EDW : Enhanced Dynamic Wedge)를 이용한 조사방법과 비교하였다. 3차원 치료계획장치를 이용하여 선량분포 최적화를 수행하였으며 계산 결과의 정확도를 검증하기 위해 인체 팬톰과 모스펫 측정기를 사용하여 측정을 수행하였다. 동측 유방 입사면 가장자리로부터 반대편 유방 쪽으로 2, 4, 6, 8, 10 cm 지점을 선정하여 각각 표면(0 cm :가피)과 0.5 cm(진피) 깊이에서 선량을 측정하였으며, 0.5 cm 깊이 선량측정을 위해서 0.5 cm 볼루스를 사용하였다. 선량분포의 계산은 불균질 물질을 보정(modified Batho method)하여 0.25 cm 격자 해상도로 수행하였다. 결 과 : 치료계획장치에서 각 지점의 평균표면선량은 금속쐐기의 경우 표면 및 0.5 cm 깊이에서 19.6~36.9%, 33.2~138.2% 증가했고, 동적쐐기는 1.0~7.9%, 1.6~37.4%까지 증가하였다. FIF는 -18.4~0.7%,-8.1~4.7%까지 선량이 변화하였다. MOSFET을 이용하여 측정한 경우는 금속쐐기는 표면 및 0.5 cm 깊이의 경우 11.1~71%, 22.9~161.2% 증가했고, 동적쐐기는 4.1~15.5%, 8.2~37.9% 선량이 증가했다. FIF는 표면에서-15.7~-4.9%로 선량이 오히려 감소했으며, 0.5 cm 깊이에서의 선량도 -10.5~3.6%로 나타났다. 치료계획장치의 계산값과 실측값을 비교한 결과, 유사한 경향을 보였으나 치료계획장치의 경우 피부선량이 실제측정값보다 다소 과소평가되고 있음을 알 수 있었다. 결 론 : 본 실험을 통해 FIF치료방법의 경우 기존 치료방법(MW, EDW)에 비해 치료표적에 최적화 된 선량 분포를 만들어 내면서도 반대편 유방의 피부에 불필요한 산란선량을 최소화하는 치료방법임을 알 수 있었다. The aim of this study is to evaluate contra-lateral breast (CLB) surface dose in Field-in-Field (FIF) technique for breast conserving surgery patients. For evaluation of surface dose in FIF technique, we have compared with other techniques, which were open fields (Open), metal wedge (MW), and enhanced dynamic wedge (EDW) techniques under same geometrical condition and prescribed dose. The three dimensional treatment planning system was used for dose optimization. For the verification of dose calculation, measurements using MOSFET detectors with Anderson Rando phantom were performed. The measured points for four different techniques were at the depth of 0 cm (epidermis) and 0.5 cm bolus (dermis), and spacing toward 2 cm, 4 cm, 6 cm, 8 cm, 10 cm apart from the edge of tangential medial beam. The dose calculations were done in 0.25 cm grid resolution by modified Batho method for inhomogeneity correction. In the planning results, the surface doses were differentiated in the range of 19.6~36.9%, 33.2~138.2% for MW, 1.0~7.9%, 1.6~37.4% for EDW, and for FIF at the depth of epidermis and dermis as compared to Open respectively. In the measurements, the surface doses were differentiated in the range of 11.1~71%, 22.9~161% for MW, 4.1~15.5%, 8.2~37.9% for EDW, and 4.9% for FIF at the depth of epidermis and dermis as compared to Open respectively. The surface doses were considered as underestimating in the planning calculation as compared to the measurement with MOSFET detectors. Was concluded as the lowest one among the techniques, even if it was compared with Open method. Our conclusion could be stated that the FIF technique could make the optimum dose distribution in Breast target, while effectively reduce the probability of secondary carcinogenesis due to undesirable scattered radiation to contra-lateral breast.